United Kingdom: England

Following months of uncertainty, the UK government confirmed in March this year that the country would not be participating in the Unified Patent Court (UPC). The nation’s patent practitioners must now figure out how best to adapt their plans; prior to the UPC announcement, many had already made attempts to cement their presence in the wider European patent landscape post-Brexit by either building up existing offices or establishing new bases in jurisdictions such as Germany, France and – increasingly – Ireland. In the meantime, the United Kingdom maintains its status as a patent litigation hotspot. In the wake of last year’s seismic Unwired Planet v Huawei FRAND trial – the first of its kind in the United Kingdom – litigators are nervously awaiting the Supreme Court’s decision on appeal. If it falls in Unwired Planet’s favour, the jurisdiction is set to see an explosion of telecommunications patent litigation over the next few years.

Firms: litigation

Firms: prosecution

Firms: transactions

  • Highly recommended
  • Allen & Overy LLP
  • Anderson Law LLP
  • Bird & Bird LLP
  • Bristows LLP
  • Gowling WLG 
  • Linklaters LLP
  • Simmons & Simmons LLP
  • Stephenson Harwood LLP
  • Recommended
  • Browne Jacobson LLP
  • Carpmaels & Ransford LLP 
  • Charles Russell Speechlys
  • Cooley LLP
  • Covington & Burling LLP
  • Freshfields Bruckhaus Deringer LLP
  • Herbert Smith Freehills LLP
  • Hogan Lovells
  • Marks & Clerk
  • Norton Rose Fulbright LLP
  • Pinsent Masons 
  • Potter Clarkson LLP
  • Reed Smith LLP
  • Wiggin LLP 

Alembia Intellectual Property Ltd

Founded in 2017, Alembia Intellectual Property has been unrelenting and untameable in its ambitions and successes, thanks to the skill and reputation of directors and founding partners Lucy Padget and Nonny Jones. The “seasoned strategists” bring abundant experience from AstraZeneca, giving them a unique perspective that clients appreciate: “They understand and are accustomed to meeting the requirements of large multinational companies. Flexible, focused and committed, they handle projects necessitating exacting attention to detail very efficiently.” Padget has spent 20 years at the IP coalface and is dual-qualified in the United States; “She has a good strategic international overview, alongside a technically agile mind.” Jones is no less popular with clients: “He is an extremely well-prepared, diligent and committed person whom you definitely want on your side. In addition, his charming personality makes it very easy to work with him under pressure.”

Allen & Overy LLP

Allen & Overy remains a bellwether on the UK patent litigation market. Its all-star group “benefits from exceptional support provided by the wide full-service international firm”, and has been going from strength to strength of late. The ensemble thrives in particular in life sciences and telecommunications, and continues to be involved in landmark litigation for Huawei in its parallel suits against Conversant and Unwired Planet. This precedential work is spearheaded by power trio Mark Heaney, Neville Cordell and Mark Ridgway. With Heaney, “you get a wealth of knowledge and experience, and the security that you’re taking calculated risks in a considered way”. His technical understanding is second to none, thanks to hands-on experience in electronic engineering and computer science. “Standout individual” Ridgway is likewise hailed for his technical aptitude; he is further a noted authority on trade secret litigation. Cordell is “extremely capable, hardworking and very nice to work against and alongside”. He is a hot property right now thanks to blockbuster litigation not only for Huawei, but also for Samsung, LG Electronics and Seoul Semiconductor. Impressively, he recently went to the Supreme Court with three patent cases over the course of a mere six months. Also crucial to the team’s success are Marc Döring and Marjan Noor, who have “immense expertise, experience and sound judgement”. Life sciences and consumer products specialist Döring keeps the big strategic picture in mind when representing the likes of Bayer, Eli Lilly and Procter & Gamble. Also celebrated for his diplomacy, he is “always open with advice on managing the internal company politics of a situation”. Noor has a similar penchant for life sciences, and displays “exceptional skill and care” when tackling matters of the utmost complexity. Jim Ford and Nigel Parker are responsible for some of the firm’s sector-shifting transactional work. They recently advised Hewlett-Packard on its acquisition of Apogee and facilitated the negotiation of a collaboration agreement between Grünenthal and Mesoblast.

Anderson Law LLP

Transactional force Anderson Law has significantly increased its headcount, which now stands at 14 fee earners, up from 10; and five partners, up from three. It is making this count where it matters on myriad high-rolling deals, including many for universities and their spin-outs. Alongside partner Lisa Allebone, founder Mark Anderson has been busy in the technology transfer space for the University of London and CellCentric Limited, a spin-out from the University of Cambridge. According to clients, the esteemed pair “provide an excellent service and give considered and prompt responses to queries”. “With them, you are in good hands. They carefully consider the legal and commercial issues, and move contractual matters along swiftly.” While Allebone and Anderson are both experts in life sciences, this is by no means a limit to the firm’s remit, as other practitioners on the growing team specialise in everything from telecommunications to computer science.

Appleyard Lees 

The practitioners at Leeds-based outfit Appleyard Lees embed themselves in clients’ businesses and understand just what those businesses need and how best to deliver it. As a result, they form close, long-lasting bonds with patrons. The firm’s five offices are strategically located close to technology and life sciences hubs, in order to capitalise effectively on the full breadth of innovation in the United Kingdom. In Leeds, Bobby Smithson comes armed with dual credentials in chemistry and law, and is an expert manager of large patent portfolios. He also ventures regularly to the EPO, where he recently prevailed in an unusually complex two-day opposition regarding a patent in the field of chemicals and coatings. In Manchester, Simon Bradbury is wowing industry heavyweights with his prolific life sciences practice. To quote one superlative review: “In my 35-year career, I have worked with multiple patent attorneys in biotechnology and healthcare, and have found Simon to be the most outstanding. He is meticulous in his preparation, extremely thorough in the construction of our patents and makes the patenting process a straightforward one.”

Bird & Bird LLP

Recognised worldwide for its contentious capabilities, Bird & Bird is a tour de force in the life sciences, high tech and telecoms spheres. Its patent litigation group – vast and rich in quality – has been busy this year litigating for clients as varied as Nokia, Takeda and Kingfisher, the parent company of hardware retailers B&Q and Screwfix. “Star practitioner” Morag Macdonald is recognised as “technically astute, knowledgeable on UK and German patent matters, and excellent at collaborating with in-house teams and colleagues in Bird & Bird’s wider global litigation practice”. Working alongside her is Richard Vary, an authority on FRAND matters whose expertise in telecommunications stems from a stint as head of litigation at Nokia. Equally in demand in this field is Jane Mutimear, a seasoned litigator who has recently turned some of her attention to Pattern, a patent portfolio intelligence product developed in-house.  Other stars in Bird & Bird’s constellation of litigators include department heads Katharine Stephens and Robert Williams. Williams is “not only an excellent lawyer who communicates with candour, but a very pleasant personality to work with”. Also garnering praise is Mark Hilton, a tenacious patent litigator who additionally dispenses incisive strategic advice in the areas of pharmaceuticals and biotechnology. This technical specialism is something he shares with colleague Jennifer Jones, an “accomplished advocate with a strong ability to assess the quality of potential expert witnesses”; and pan-European litigation strategist Neil Jenkins, who boasts impressive knowledge of supplementary protection certificates (SPCs). The firm’s pharmaceutical prowess is strengthened further still by Patrick Kelleher, a silky-smooth coordinator of pharmaceutical and biotech suits across Europe and the world. On the transactional front, the key figures are Sally Shorthose and Tom Snaith. Shorthose impresses with her savvy advice on regulatory and freedom-to-operate issues and confident brokering of licensing agreements; while “user-friendly” Snaith acts for private equity firms and corporate clients on complex high-value IP transactions. He also regularly conducts IP audits and holds the unusual distinction of an academic background in chemistry.

Boult Wade Tennant LLP

Expansion is the central narrative at Boult Wade Tennant right now: it recently opened a Berlin office to build out its European reach. At home in the United Kingdom, it needs no introduction as a top prosecution shop that files prolifically and handles oppositions and appeals with exactitude. Two attorneys who win plaudits for their experience and proficiency in administrative proceedings are Oxford-educated Rohan Setna, who has a specific flair for semiconductors; and Cambridge alumnus Adrian Hayes, a chemist who attends more than 20 oppositions and appeals each year before the EPO. Also known for his opposition appearances, and for his doughty technical support in heavy-duty High Court litigation, is Nick McLeish, who leads the high-tech and electrical group. Heading up the life sciences group, Matthew Spencer has keen insight into diagnostic technologies, pest control, stem-cell technologies and fermentation processes. He manages the Almac Group’s large patent portfolio alongside Nina White, a biotech specialist who knows her stuff when it comes to therapeutic antibodies. Automotive veteran Tony Pluckrose has an affinity for technologies at the crossroads of electrical and electronic engineering. Finally, physicist Jonathan Palmer’s practice sits on the increasingly blurred line between high tech and biotech; he can often be found analysing research programmes and advising on the strength of different aspects for patent protection.

Bristows LLP

Bristows is one of the most potent and respected IP outfits in the United Kingdom, with a whopping 12 partners dedicated purely to patent litigation. Providing exceptional leadership are Brian Cordery and Myles Jelf, who both attract resounding praise. “One of the guiding lights of English patent litigation practice”, Cordery is beloved by pharmaceutical clients for his stellar coordination of multi-jurisdictional cases. The “exceptionally well-informed” Jelf “provides targeted senior oversight of complex matters”. Another essential weapon in Bristows’ arsenal is Dominic Adair, an “excellent practitioner” for freedom-to-operate analyses and SPC questions. His academic background in natural sciences and zoology, coupled with extensive experience of cross-border litigation, makes him a natural fit for pharmaceutical and biotech players. Bristows mainstay Edward Nodder is another skilled international coordinator who has been racking up wins at the firm for more than 40 years. Meanwhile, James Boon “gives his attention to every part of a case”; a refined technical understanding informs his advice on patent disputes in the telecoms, electronics, aeronautics and oil and gas fields. Providing similarly astute guidance on a regular basis is Liz Cohen, a life sciences doyenne whose qualification as a solicitor-advocate comes in extremely handy at the High Court. Further talent can be found in the form of Andrew Bowler, who has recently been spending time at the Court of Justice of the European Union (CJEU); and Robert Burrows, a skilled international coordinator with deep knowledge of European litigation and a prophetic perspective on issues pertaining to the UPC. On the transactional side, Fiona Nicolson and Matthew Warren have their fingers on the pulse as far as new technologies are concerned, and love helping life sciences and technology outfits to take flight in new markets. Finally, the practice is on track to receive a significant boost in the coming months, following the arrival of Richard Dickinson – a transactional specialist of 25 years’ standing with an academic background in biochemistry and an instinctive grasp of the IP aspects of corporate deals.

Browne Jacobson LLP

The future is nothing but bright for Browne Jacobson, a firm noted for its drive, youth and dynamism. It has grown significantly in strength and depth, and offers a full suite of services, from IP audits to major multi-jurisdictional litigation. Its well-established transactional practice, led by Selina Hinchliffe, has a sterling reputation in the engineering space, with Hinchliffe the darling of automotive, aerospace, and energy and utility companies. On the contentious front – where the focus is primarily on electronics and telecommunications – seasoned veteran Mark Daniels leads the charge; he is famed for his historic work for InterDigital against Nokia and continues to fight tooth and claw for diverse and discerning clients in the UK IP Office (UKIPO), the IP Enterprise Court (IPEC) and the High Court on a regular basis. Meanwhile, software patent expert Giles Parsons is riding high right now, having managed a component of the game-changing Unwired Planet litigation.

Carpmaels & Ransford LLP 

“Solid and reliable,” Carpmaels & Ransford continues to fire on all cylinders in the United Kingdom and beyond. Both its venerable prosecution practice and its increasingly lauded contentious division demonstrate particular prowess in the life sciences; as a result, the firm has enticed eight of the world’s top 10 pharmaceutical companies onto its client roster. On the prosecution side, the presence of “leading biotechnology specialists” such as Daniel Wise, Hugh Goodfellow, Cameron Marshall, Harvey Adams, Edward Oates, and James Warner cements its reputation. Wise is a “trusted adviser in the pharmaceutical space”; while head of life sciences Goodfellow shines in numerous oppositions and appeals at the EPO. Marshall steps in at an early stage to devise cogent strategies in anticipation of future patent battles; while Adams is known for his expert tackling of freedom-to-operate issues. Oates is a lifecycle management sage who, along with Warner, has extensive experience conducting opposition proceedings against multiple opponents at the EPO. The team also features the likes of IT and telecoms whizz John Brunner, managing partner Richard Jackson and Chris Tunstall, who garners plaudits for his adroit long-term management of a huge medical device patent portfolio for life sciences giant Johnson & Johnson. Chemist Susan Kirsch is noted for her flourishing opposition and appeal practice in fields as varied as consumer products, food science and polymers. On the contentious side, a recent uptick in instructions is in no small part due to the efforts of “high-flyers” Camilla Balleny, David Wilson and Ian Kirby, who go out to bat for the firm’s A-list pharma clientele. As captain of the litigation arm, Balleny “has entered an elite club and has become a highly respected figure of the British patent litigation market”. Regularly engaging in multi-jurisdictional litigation between companies in the pharmaceutical and telecoms sectors, Wilson makes even the most complex patent disputes look easy. Kirby “conveys information in a manner that is easy to understand, is always available and dispenses business-savvy advice. His approach is a reasoned one, logically working through problems”. Dealmaker and rising star Jake Marshall is doing an “excellent job” providing strategic advice on cross-jurisdictional IP-related settlement agreements.

Charles Russell Speechlys

David Fyfield is the patent litigator to call at Charles Russell Speechlys, an outfit known for its strong commercial practice. He works primarily in the high-tech field, with software disputes a forte. He and his firm also provide strategic advice to clients at the design stage, in order to avoid potential infringement. The offering is rounded out by a pin-sharp transactional practice, which has lately been busy shepherding deals over the line in fields as varied as entertainment, renewables and pharmaceuticals.

Cleveland Scott York

The dynamic, forward-thinking prosecution unit at Cleveland Scott York has a wide remit, providing everything from initial drafting to oppositions and appeals. Among those who enlist its counsel are the technology transfer arms of academic institutions, major pharmaceutical multinationals and household names in the cosmetics industry. Whatever the technical area, the team keeps clients’ commercial interests front and centre at all times. At the fore is Tom Faulkner, who quickly gets to grips with the intricacies of new products in sectors ranging from mechanics to software. With a hands-on approach, he loves getting involved in product development.  The firm values enduring relationships and one of its longest-standing clients has high praise for engineer Fraser Brown: “His background knowledge of our business, gained across the 26 years we have worked with him, allows him to frame his advice accordingly, which has great value.” Adrian Bradley has an encyclopaedic knowledge of the product lifecycle in the life sciences and utilises this to great effect when advising universities. In a former life, Andrew Mackenzie was a design engineer for Jaguar Cars, giving him an insider’s view of the industry that proves invaluable in all manner of contentious proceedings.

CMS Cameron McKenna Nabarro Olswang LLP

Unusually, CMS is equally impressive at both prosecution and litigation: its lawyers and patent attorneys combine effortlessly to do boundary-pushing work under one roof. The firm is as confident on original drafting for Microsoft as it is in damages proceedings for Sandoz, and clients rave about its flexibility and breadth of skill. Renowned for its pharmaceutical and biotech thought leadership, it has recently made inroads into bleeding-edge areas such as AI and digital health. The prosecution stars are Helen Wallis, Robert Stephen and Jane Hollywood. Wallis “can explore very complex ideas and translate them into applications with a degree of insight that goes way beyond the expectation”.  Stephen “drafts well, is very good at working with multiple parties with opposing views and is highly trustworthy”. Biotech specialist Hollywood is also one to watch, thanks to the foothold she is carving in burgeoning fields such as plant sciences and the nascent cannabis industry. On the contentious side, plaudits flood in for the “exceptional” Gareth Morgan, who has a “deep understanding of pharmaceutical regulatory law as well as patent law”. He is part of an “extraordinary” team of litigators, which can “step back and point companies and inventors in the right direction rather than getting lost in the detail”.

Cooley LLP

This year has seen US juggernaut Cooley continue to build out its UK IP practice, tackling “serious matters for the newest, most exciting start-ups”. The linchpins of its transactional offering are life sciences mavens Nicola Maguire and John Wilkinson, both of whom were recently instrumental in Bavarian Nordic’s acquisition of two business-critical commercial vaccines from GlaxoSmithKline for a total of €796 million. This kind of high-value life sciences work is meat and drink for the firm, as is also exemplified by the efforts of Colm Murphy – a patent attorney whose results for big-name pharmaceutical and biochemical organisations have earned him a glowing reputation.

Covington & Burling LLP

The London offering of US-headquartered Covington & Burling consists of a crack team of transactional dynamos, including life sciences experts Lucinda Osborne, Daniel Pavin and Morag Peberdy. Osborne is in her element when making complex strategic collaborations a reality; while Pavin seamlessly blends IP expertise with an active commercial practice, advising on the IP aspects of lucrative mergers, acquisitions and strategic investments. Solicitor-advocate Peberdy is an invaluable asset to clients with aspirations to reform the law in this area.

D Young & Co LLP 

D Young & Co is a “strong, consistent performer” in a plethora of technical fields. The EPO is like a second home to its practitioners, 55 of whom are qualified to practise there. On the prosecution side, the firm filed about 2,000 European patents in 2019, as well as undertaking heavy-duty oppositions for the likes of Teva and DuPont. Given this astonishing rate of activity, it is unsurprising that no fewer than seven Young & Co patent attorneys make it into the IAM Patent 1000 this year. Garreth Duncan matches incisive SPC knowledge with “attention to detail, advocacy for clients’ positions, thoughtfulness and a willingness to embrace creative solutions”; while the globally minded Simon O’Brien is well versed in both biology and chemistry. At their side is Kirk Gallagher, who comes “highly recommended” for his performances in oppositions at the EPO – a skillset he shares with Charles Harding, the firm’s longest-serving life sciences partner with some 35 years under his belt. “Knowledgeable and reliable”, Jonathan Jackson has an affinity for the intricacies of hot new fields such as wearable technology and fintech. Anthony Albutt’s expertise lies in medical devices, aerospace and – notably – engineering; Toyota relies upon him to manage a large portfolio. In one client’s opinion, Neil Nachshen is “one of the best patent attorneys in the country”; he spends his time teasing out the knots of “exceptionally difficult” EPO oppositions and appeals. The trailblazer in D Young & Co’s litigation division is Antony Craggs, an “extremely careful, knowledgeable and commercial solicitor” with a “close eye for detail”. Immersing himself in the life sciences, electronics and engineering, he is “a pleasure to work with and will always go the extra mile to ensure the very best service”. His practice is supported by that of Richard Willoughby, a veteran of the patent litigation world who remains a vital asset in his role as consultant.

Dehns

“An excellent firm which covers all bases,” Dehns boasts a team of 106 patent professionals across six offices, with briefs flying in from clients across Europe, the United States and Asia. According to a recent study, it has been the United Kingdom’s top filer of European patent applications for the last four years; despite this impressive statistic, however, its mantra is always quality over quantity. It provides the full suite of premium prosecution services, including assessment of patentability, freedom-to-operate opinions, and oppositions and appeals. Philip Webber can be relied on for all of this and more – especially by start-ups, SMEs and universities with inventions in the pharmaceutical and biotech fields. Colleague David Leckey – who previously spent six years as an examiner at the UKIPO – is hailed as “very professional and a good communicator”. Elsewhere, physicist and engineer Christopher Davies has the rare distinction of being a certified patent attorney litigator; alongside filing and prosecution in the electronics and engineering fields, he is regularly involved in contentious matters and called on to provide infringement and validity opinions.

DLA Piper UK LLP

A vital cog in the wheel of one of the largest European and international patent groups, the London contingent of DLA Piper impresses on both the contentious and non-contentious fronts. Its practitioners have profound sector knowledge in pharmaceuticals, biotech, telecoms and electronics – although these are by no means the limits of its ken. On the contentious side, it is regularly involved in high-stakes patent suits across all fields; while on the transactional side, it provides commercially on-point advice on strategic asset management, licensing and the IP aspects of corporate M&A. The pacesetter in both is master tactician Richard Taylor, who recently prevailed in infringement proceedings on behalf of BMW. He has a reputation for his ability to zero in on an issue from an initial bird’s-eye view and generously shares the knowledge he has gained over his 20-year career by teaching at the University of Sheffield. The firm recently announced the arrival of former Pinsent Masons partner Deborah Bould, an experienced patent defence and enforcement specialist who recently set a precedent with respect to the determination of global RAND royalty rates which allows technology manufacturers and distributors to exit UK litigation where such rates would be decided.

EIP Europe LLP

EIP “blends litigation and patent prosecution in a seamless team”. While the firm is historically known for its prosecution nous, the contentious group – formed seven years ago – is now coming into its own, with five partners and 12 associates and trainees on the bench. “The lawyers really put their heart into the case and there is never even a single moment’s doubt that they have their clients’ interests first and foremost in mind.” Its reputation in the field of SEPs is difficult to beat, while its European reach is expansive, thanks to a trio of EIP partners also stationed in Dusseldorf. Gary Moss is a “very switched-on patent litigator with a wide commercial perspective and strong legal knowledge”. In particular, he has a deep understanding of FRAND issues and SEPs, having recently been involved in the notorious Unwired Planet v Huawei case; his know-how in other areas is also vast, thanks to the countless cross-border IP disputes he has tackled during 30 years on the frontlines. Robert Lundie Smith is a dab hand at overseeing parallel proceedings in multiple jurisdictions and was also key to the Unwired Planet litigation. Another FRAND suit – this time for PanOptis against Apple – has been keeping talented litigator and SEP specialist Kathleen Fox Murphy busy lately; while biochemist Matthew Jones does not limit his contentious prowess to his field of study, having been involved just this year in major electronics work for Vestel. Personifying the firm’s integrated approach is Laurence Brown, a patent attorney who has been hard at work providing technical support in litigation at both the Patents Court and the IPEC. The firm’s prosecution arm is likewise rich in talent: Matt Lawman is “very knowledgeable, timely and has great attention to detail”; while fellow electronics buff Jerome Spaargaren brings personal skill and insight as an inventor to the table for clients. Meanwhile, Heather McCann can frequently be found in Silicon Valley advising US technology start-ups and SMEs on their European prosecution strategy. This “consistent and high-quality” practitioner has “excellent technical knowledge” – something that colleague Darren Smyth also boasts in spades. His expertise ranges from life sciences to semiconductors.

Forresters

The venerable Forresters has been providing clear, uncomplicated patent prosecution counsel and services to clients since 1884, and continuously strives to expand and improve its offering: over the last two years, for example, it has taken on four new partners and opened a fifth UK office in Southampton. In addition to filing patents and appearing in administrative proceedings, the team provides expert opinions on potential infringement, freedom to operate and due diligence; it is also well placed to advise on SPC matters. The firm is characterised by a European outlook, thanks to vital support from an outpost in Munich helmed by the reputable Matt Barton, who receives mention in the Germany rankings. Barton is doubtless visited frequently by London’s Jonathan Gowshall, who is regularly in the city to appear in EPO oppositions and appeals. This “smart and practical representative” has notched up an astonishing success rate of over 90%, while also providing freedom-to-operate opinions and supporting litigation in the areas of biotech, pharmaceuticals, food science and medical devices.

Freshfields Bruckhaus Deringer LLP

Freshfields has significantly boosted its IP litigation practice in recent years – not least thanks to the efforts of the “very bright and sharp” Christopher Stothers. With a “remarkable track record in biotechnology”, he has also hammered out the wins in strategic cross-border patent disputes in all technological fields, including medical devices, software and telecoms; and is further adept at oppositions before the EPO. Fighting alongside him is the high-flying Laura Whiting, who has the answers to even the most complex SPC questions and a wealth of scientific knowledge across the technical spectrum. Freshfields also advises on market-defining patent-driven transactions, particularly within the electronics and telecoms industries. The digitally minded Giles Pratt heads up the transactional practice and has a particular flair for transactions involving valuable technology and data. Standing shoulder to shoulder with him is David Brooks, whose focus is on IP transactions in the context of international M&A, joint ventures and complex carve-outs.

Gill Jennings & Every LLP

The team of patent attorneys at Gill Jennings & Every is diverse in terms of technical know-how; but whatever the sector, the quality is always consistent. Brimming with commercial acumen, it adroitly tailors patent portfolios and IP strategy to the specific needs of a varied client base. In March 2019 it acquired Beresford Crump LLP, a boutique known for its electrical engineering prowess, and its staff have integrated themselves well into the wider group, bringing valuable instructions with them and expanding the parent firm’s already impressive reach. The broad bench of talent includes life sciences specialist Arnie Clarke, a “brilliant and very knowledgeable” attorney who attends about 30 oppositions and appeals per year at the EPO and draws on this exposure to future-proof patent applications against further contentious proceedings. This approach is shared by colleague Lucy Samuels, who has applied her hawkish attention to detail to 300 hearings across the course of her career. She acts for the likes of Procter & Gamble and Rockwool International, a client that the firm has collaborated with for some 50 years. Of late, Samuels has been processing Rockwool International’s workload alongside partner Heather Scott, whose mechanical and electrical expertise extends to document-handling machines, holograms and semiconductors. Chairman Robert Skone James has a similarly varied skillset, encompassing not only the telecoms specialism for which he is best known, but also expertise in printing, document security and even undersea surveying techniques. Completing this year’s line-up in the IAM Patent 1000 is computer-implemented invention aficionado Peter Arrowsmith: he “has an open, friendly and engaging manner, quickly understands the technicalities of new ideas and has wide global patent knowledge”.

Gowling WLG 

“Gowling WLG has done a great job and has been very visible in the market this year. The IP team is very strong and clients know they can rely on it to provide high-quality, made-to-measure advice.” The outfit has an extensive network of offices in 19 cities across the world, and clients that are initially impressed by one contingent have been known to go on to instruct the firm in other locations – a trend that brings in a slew of mandates for its UK litigators. The practice was supercharged this year by the arrival of former Norton Rose Fulbright partners Jonathan Ball and Huw Evans. Ball previously served as a forensic biochemist for the Metropolitan Police, but in his 20 years as a solicitor has made inroads into other technical areas and has lately become something of a fintech sage, representing several global banks. Evans is “a trusted, respected leading IP practitioner with a collaborative, pragmatic approach and an ability to crystallise complex IP issues into a simple form and to help determine a credible way forward”. His thriving practice benefits significantly from a stint as head of life sciences at Norton Rose Fulbright and the myriad relationships he has forged across the healthcare sector. Gowling WLG is also home to antibodies and biosimilars boffin Paul Inman, who is “very easy to work with, strategically creative and commercially aware”. Renowned transactional lawyer Patrick Duxbury is additionally on hand; the former microbiologist and geneticist now spends his days brokering high-profile collaborations and licensing deals for pharmaceutical giants. Department head and engineering and technology specialist Gordon Harris is a “senior statesman of the IP world, with an outstanding reputation and an ability to see the forest from the trees”. He spent several years heading up the firm’s China office and has litigated in numerous other jurisdictions; his guidance is always “soundly rooted in business considerations”. Alexandra Brodie is “a very engaged person who busts it out and delivers for clients”. She is the person to contact with 4G and 5G patent licensing issues. Finally, litigator Jamie Rowlands recently returned from China to focus on his UK practice, which spans fields as varied as healthcare, aviation and high technology. The experience gained in his role as chief representative officer of the Guangzhou office will doubtless prove invaluable in cases with an international component.

Haseltine Lake Kempner LLP 

The ground-breaking merger of prosecution powerhouse Haseltine Lake LLP and litigation outfit Kempner and Partners in May 2019 spawned booming full-service firm Haseltine Lake Kempner (HLK), which has bases in seven locations. It is comfortable in virtually every technical sector, including both electronics and life sciences, as well as more niche areas such as food manufacturing. Household names on its client roster include Hewlett Packard: the tech titan recently split into separate bodies Hewlett Packard Enterprises and HP Inc, and HLK’s patent attorneys are kept busy filing patents for both entities. They include the “extremely thorough” Alex Rogers, whose “patent assessment and skills of oral persuasion are top notch”, yielding success in many EPO oppositions. While he works across many sectors, the life sciences is a forte. Fellow biologist David Hammond is a “patient and diligent” attorney who “takes the time to understand the invention and the organisation’s requirements, provides sound advice, and engages with inventors and management at all stages”. “He is commercially aware and proactively comments on commercial threats and opportunities.” Global head of client services Simon Rees is “top drawer in electronics patents” and “one of the most creative patent attorneys practising before the EPO”. “He and his team have got positive results when others thought our chances would be very low,” enthuses one happy customer. On the contentious side, Richard Kempner has chalked up more than 30 years in the game and focuses on developing IP strategies for companies as varied as Netsweeper and Tesco.

Herbert Smith Freehills LLP

“The quality at Herbert Smith Freehills is really first class. There are a number of standout individuals and collectively as a team they really produce the goods.” Best known for its work in the pharmaceutical sphere, the firm advises 80% of the leading players in the field and has a percipient take on SPC issues; telecoms is another stronghold, especially when it comes to SEPs and FRAND licensing. Captaining the global IP group is Mark Shillito, a versatile litigation and transactions pro who is adept at pre-litigation strategy and multi-jurisdictional dispute coordination. Solicitor-advocate Sebastian Moore is applauded for his “excellent advice, well-thought-through strategy and client-orientated thinking”; together with Sophie Rich, he was involved in a precedential win for Roche in a High Court case on the hot topic of Arrow declarations. Rich is a learned biologist who frequently acts as lead partner on pan-European patent enforcement actions and is “very easy to work with, thorough, reasonable and balanced in her approach”. “Extremely skilled in terms of both strategic considerations regarding patent enforcement and legal skills in arguing the case,” Jonathan Turnbull advised on the influential Unilever v Shanks matter, which came before the Supreme Court in 2019 – a mission he undertook alongside Andrew Moir. A newcomer to the IAM Patent 1000, Moir specialises in high-tech patent disputes, having gained hands-on experience in electronics and software prior to joining the legal profession. Finally, Joel Smith’s remit is wide, with routine work on life sciences transactions and licensing agreements complemented by an active practice providing strategic advice on contentious matters for the likes of British American Tobacco and Standard Bank.

HGF Ltd 

HGF’s ambitious growth strategy has resulted in 22 bustling offices across Europe, from which it pools resources and assembles multi-disciplinary teams to undertake complex cross-jurisdictional patent prosecution. Its diverse clientele includes major pharmaceuticals and telecoms multinationals, British universities and leading auto manufacturers. The firm’s technical nous is underpinned by the varied backgrounds and skillsets of its robust bench of talent. First among equals is senior partner Harry Hutchinson, a commercially focused telecoms expert whose previous career as a radio frequency engineer makes him a marvel on all things wireless. Hsu Min Chung has a penchant for chemistry and material science; her practice is informed by a stint in the patent department of a FTSE 100 oil and gas company. She has been hard at work preparing a series of administrative proceedings for a major tobacco company alongside fellow chemist Chris Moore, who is head of oppositions and appeals. The “pragmatic” Janet Knowles is hailed as a “consistently high-quality legal adviser with a broad range of knowledge”, who is “effective and efficient”. “She has worked for our company over a significant period and her advice has always been sound and all documents constructed have stood the test of time,” reports one patron. Jennifer Uno attracts similarly effusive feedback: “Jenny knows our needs very well and surprises us by advancing on solutions for our IP matters at the soonest opportunity. She is always extremely easy to reach, will make time to know more about the company, and will not miss a small gap left in the prosecution of your files or in your new invention. Her creative disposition when it comes to ideas and solutions on how to accommodate our needs or demands are difficult to find elsewhere.” In addition to precision prosecution, “brilliant attorney” Matthew Cassie provides infringement and validity opinions and advises start-ups on the IP aspects of commercial transactions and M&A. Also in demand for his infringement and validity opinions is Andrew Wells, who shines in the pharmaceutical and chemical spheres. Last but by no means least, “great, pragmatic leader” Lucy Johnson impresses with her engineering know-how, which stretches from straightforward matters such as joist hangers and packaging to more arcane areas, including water treatment systems, welding and oil and gas technology.

Hogan Lovells

The unanimous consensus on the UK patent market is that Hogan Lovells is “absolutely among London’s most successful and sought-after patent teams”. Some would even go so far as to say that it has “the best all-round patent team in London” – kudos based on its “enormous strength in depth” and “the approachable faces of the people working there”. In addition, it garners special acclaim as the only firm to have won every Supreme Court patent case in which it has been involved. More widely, Hogan Lovells’ abundant global resources – it has 260 patent lawyers on hand worldwide – ensures a uniquely strategic approach in major cross-border disputes. In terms of expertise, the group has dual specialisms in life sciences and telecoms. A representative from one pharmaceutical giant reports: “Over the years, I have worked with Hogan Lovells in relation to nearly a dozen products. Large companies like us only stay with law firms if they think they are getting great service; and to me, the fact that over my entire career we have used Hogan Lovells speaks volumes.” A rainmaker in the life sciences is Stephen Bennett, whose “pragmatic realism is legendary” and who “makes the right calls consistently” – “working with him is a pleasure, because there is no unnecessary stress”. Fellow life sciences torchbearer Daniel Brook is “great on the technical side, with a deep understanding of the issues underlying a case”; recent highlights of this “master of impartiality and prudence” include Supreme Court victories for both Eli Lilly and Werit. The stars on the telecoms side are Paul Brown and Katie McConnell. According to one peer, Brown is “the leading telecommunications litigator in the country” and is “hugely respected because of his ability to explain the technology to the lawyers and the law to the inventors”. He juggles his contentious practice with advisory responsibilities, which include providing guidance on licensing disputes, the overlap between IP and competition law and FRAND obligations. Equally holistic in her approach, McConnell is prolific both in litigation and in the drafting and negotiation of IP licensing agreements. While she embraces both technical specialisms of the firm, she recently played a crucial role in precedential case challenging the interpretation of EU legislation on paediatric extensions.

J A Kemp

J A Kemp retains its “first-class” reputation this year thanks to its meticulous prosecution for household names across a range of sectors. With three UK offices and outposts in Paris and Munich, the firm is ideally placed to provide a joined-up service not only to clients from across the continent, but also to players from the United States and Japan seeking to protect their innovations in the region. It has a particular facility for patent restoration, obtaining SPCs and providing all-in-one IP advice incorporating patents, trademarks and related litigation. With 80 science and technology graduates on board – 45 of whom hold PhDs – the firm’s scientific acumen can be measured by the bucket-load. Pharmaceuticals is a current focus for the UK group, as evidenced by recent work for Sanofi and Abbvie. Leading on the Sanofi matter, Ravi Srinivasan is “really proactive, on the ball, easy to work with and knowledgeable”. In addition to his pharmaceutical practice, he assists players in the burgeoning cleantech sector. Fellow life sciences specialist Simon Wright “is a true partner – you know you can rely on his judgement and advice”. With three decades of IP experience under his belt, he is never fazed by projects of a daunting scale. Other biotech specialists include Sarah Roques, who has all the answers on antibody patents and speaks regularly on the topic; and Patrick Campbell, whose “skill at forging human connections” makes him a client favourite: “He is knowledgeable about patent strategies, very responsive and accommodating on schedules.” Medical devices expert Mark Roberts is celebrated for his “resourcefulness and tenacity in dealing with issues”, and his “refreshingly creative approach”. As the firm’s nominated monitor of changes in worldwide patent law, he is a fount of knowledge for colleagues and clients alike.

Keltie LLP 

Keltie is unswervingly committed to client service, with a view to offering optimal commercial support and maintaining the strongest, most enduring relationships. Its patent attorneys are regularly embedded in in-house teams in order to provide cost-effective, on-the-ground assistance and further enhance its client relationships. This ethos has paid off handsomely, as one satisfied patron attests: “We have worked closely with Keltie for more than 20 years. Over this period, it has positioned itself as an extension of our own team through its intelligent, customer-focused approach and methodology. Keltie has managed to take the complexities of the world of IP and present them to us in a clear way. The team is exceptional in every sense and is always on hand to offer support, advice and guidance in a way that consistently strives towards a long-term solution in the best interests of the client.” Automotive specialist Joanne Hopley embodies this approach; she “has vast experience, understands inventions and knows how to question and communicate directly with inventors wherever they are based”. Likewise Devanand Crease, who has made an impression on peers with his “vast understanding of biochemistry and other life science fields”. With expertise in genomics, epigenetics and medical devices, he provides shrewd strategic guidance and support to companies across the United Kingdom, the United States and Asia. Also acclaimed are “forces to be reckoned with” Judith Caldwell and Jonathan Goodacre. Caldwell has spent 25 years with the firm, working in such diverse fields as chemistry and polymer science, veterinary science and cosmetics; while Goodacre marries keen biochemistry acumen with industry insight gleaned from his time as a principal scientist at GlaxoSmithKline. Fellow biochemist Michael Moore is lead partner in Cambridge, just a stone’s throw away from his alma mater. In addition to regular appearances in oppositions and appeals before the EPO, he receives a wealth of instructions from the United States. On the software side, Shakeel Ahmad has a thriving fintech practice and a flair for software inventions on the borderline of patentability. Keltie’s all-star team is now supported by a further four permanent staff members based in Galway. While the recent opening of the Irish office was a wise move, given the uncertainties surrounding Brexit, the robustness of its offering demonstrates that this venture is a serious one that seeks to tap into Ireland’s booming start-up culture.

Kilburn & Strode LLP

An impressive eight Kilburn & Strode patent attorneys appear in the IAM Patent 1000 this year, reflecting the depth and breadth of quality on its bench. The firm – which recently moved into a brand-new state-of-the-art HQ in London – places people firmly at the centre of its offering. As a reflection of this, in a ground-breaking move, it has also opened an office in Silicon Valley, to provide West Coast innovators with in-person face time. “Everyone at Kilburn & Strode is highly responsive, thorough and top quality. They only hire the best, and it shows in their interactions, client counselling and results.” Managing partner Richard Howson’s combination of IP expertise and technological know-how has led to great success in the aerospace and automotive sectors. He has represented a major aircraft manufacturer before the EPO for a decade now and recently took on the portfolio of electric vehicle start-up Arrival. Arrival also benefits from the AI expertise of Alexander Korenberg, a tech maestro who has “a solid grip on the legal aspects of patent prosecution and is extremely technically savvy”. Engineer Jim Miller is another client favourite: “Highly intelligent, commercial and technical, Jim is committed to finding ways to add value, and can be dropped into the heart of a business with confidence that he’ll deliver the right advice in the right way.” Antibody specialist Tom Leonard “picks matters up very quickly and will always go out of his way to assist, even at very short notice”. Other life sciences mavens include Nick Lee, Kristina Cornish and Nick Bassil. Lee handles the hefty patent portfolio of Immunocore, a leader in T cell receptor technology; while Cornish provides SPC-related advice and contentious support to Janssen. Bassil is also well versed in SPCs and has lately been involved in a series of immunotherapy cases on behalf of the University of Pennsylvania. Completing the line-up is chairman Gwilym Roberts, who needs no introduction to anyone with even a fleeting knowledge of the European patent space – not least thanks to his roles as both honorary secretary of the UK Chartered Institute of Patent Attorneys and president of the UK group of the Union of European Patent Attorneys. He provides “outstanding practical and commercial advice for IP and patent strategies”.

Kirkland & Ellis LLP 

The UK contingent of US giant Kirkland & Ellis has seen stratospheric growth recently, due to the judicious lateral hire of 11 IP practitioners, including “one of the best on the UK market”, Nicola Dagg. The firm is known Stateside for its driven, commercially focused style and the creative trial-based approach of its lawyers – a model that it is successfully replicating in London. With the formidable new team comes a wealth of contentious talent in both life sciences and telecoms: Dagg has put her abundant skills and experience to good use in a FRAND licensing dispute for Xiaomi, and in heavy-duty litigation for Regeneron. Working alongside her is Steven Baldwin, whose telecoms know-how is matched with an encyclopaedic knowledge of SPCs that proves priceless in complex cross-border life sciences disputes. Meanwhile, Daniel Lim – another life sciences genius with the ability to quickly unpick the most arcane biochemistry issues – is having a seismic impact through his work with Novartis, for which he secured a vital interim injunction in January 2019.

Lewis Silkin

Thanks to the shrewd acquisition of patent and trademark attorney firm Ablett & Stebbing, Lewis Silkin has significantly ramped up its patent prosecution capability in recent months, with high-calibre instructions across a diverse range of fields flying in as a result. Impeccable filing and drafting are accompanied by appearances in EPO oppositions on behalf of clients such as healthcare company Owen Mumford Limited and Ørsted Wind Power A/S, Denmark’s largest energy company. At the fore is the “entrepreneurial and well-connected” Tom Gaunt, an “efficient, dedicated and sharp patent attorney” with deep expertise in telecoms, streaming and cloud computing services.

Linklaters LLP

With a tight network of offices across the entire continent, Linklaters makes light work of sprawling pan-European and international disputes. Unusually, its contentious and transactions practices are of equal significance, and High Court advocate Ian Karet straddles the two with ease. In line with the technical focus of his firm, he has been bringing the heat this year in major multi-jurisdictional pharmaceutical and biotech suits, while simultaneously brokering high-value transactions, such as a complex carve-out of Nestlé Skin Health from its parent company. Yohan Liyanage – a neuroscientist who counts Sanofi and Takeda among his clients – is another multifaceted individual, marrying trial skill with transactional nous. Also among the ranks is consummate dealmaker Nemone Franks, a fintech expert who advises on some of the highest-value IP agreements in this rapidly growing area.

Marks & Clerk

“Extremely strong and well regarded”, the full-service Marks & Clerk has all bases covered, with its pioneering one-stop shop model featuring both lawyers and patent attorneys. High-tech giants and pharmaceutical multinationals flock to the firm with cross-jurisdictional litigation and transactions instructions, alongside routine filing and prosecution tasks. On the prosecution side, Philip Cupitt’s knowledge of AI is so impressive that the prestigious Journal of the Chartered Institute of Patent Attorneys recently published his deconstruction of the EPO’s practice for examining AI inventions. He protects some of the world’s most cutting-edge AI technology, together with partner Philip Martin – a fellow software expert whose success rate in oppositions before the EPO exceeds 90%. In the pharmaceutical field, the oppositions and appeals star is Sheila Wallace, who also has intimate familiarity with the ins and outs of SPC; as do chemist Will Nieuwenhuys and head of life sciences Mike Gilbert. “Mike is very experienced and respected, able to handle very complex cases, client oriented and pragmatic.” “He sees the whole picture when providing legal advice, has really good knowledge of the pharmaceutical industry and stays calm under pressure.” Fellow litigator Graham Burnett-Hall is “very professional and reactive” and similarly well versed in pharmaceutical matters, having acted in a big-ticket case for Roche this year. FRAND and SEP specialist Dafydd Bevan can “burn the most complex issues down into the simplest language and crystallise the risks that are at the heart of the case”. Elder statesman Gregor Grant is a renowned litigator whose recent work includes suits relating to the burgeoning area of Arrow declarations. Michael Moore juggles extensive contentious work with advice on commercial and regulatory patent matters and his role as head of the transactional practice. For transactions, virtual reality specialist Simon Portman is also on hand; many companies have transformed from SMEs to industry leaders in the time they have been working with him.

Mathys & Squire LLP 

Patents are filed prodigiously by Mathys & Squire, which handles more than 3,230 filings handled over a 12-month period. However, this is just one component of its A-to-Z approach to patent protection: the firm also provides invaluable assistance in contentious scenarios, from appearances in oppositions and appeals to vital technical opinions in high-stakes litigation. “Everyone there is welcoming and friendly, and seems genuinely keen to help you make the most of your intellectual property,” enthuses one client. “They showed an excellent balance of lateral thinking, pragmatism and ambition for our invention. Some of their suggestions even went beyond drafting the patent and into ideas that might improve the invention itself.” This hands-on approach has seen the side inundated with instructions across sectors such as clean technology, automotive, pharmaceuticals, medical devices and sports manufacturing. One key client in the latter field is New Balance, which is ably served by Jane Clark; she recently convinced the EPO that its technology was patentable, despite resistance from examiners. “She develops new skills for new areas that we get involved in, is creative in finding solutions to difficult obstacles and is very prompt, with strong attention to detail and execution.” Esteemed electronics expert Ilya Kazi “has particular skills at managing complex technical and procedural matters before the EPO and is seldom, if ever unsuccessful in matters he handles”. Chemistry maven Chris K Hamer knows all there is to know about ionic liquid technologies and routinely shares his wisdom by lecturing to chemistry and chemical engineering students at Queen’s University Belfast. The firm’s resident biotechnologists include Martin MacLean and Craig Titmus: MacLean showcases his knowledge on the targeting of bacterial toxins through his work for Ipsen Bioinnovation; while sustainable technology start-up Colorifix calls Titmus a “lifesaver” for his slick management of its fabric dye patent portfolio.

Mewburn Ellis LLP

Longevity is a core value at Mewburn Ellis – the firm has been on the scene for over 150 years and has worked with 45% of its patrons for at least two decades. Thanks to these enduring relationships, the practitioners here know clients and their industries inside out – unique insight which has drawn eight of the country’s top 10 universities through its doors, as well as some of the most innovative multinationals in all sectors. In the life sciences, the firm has an abundance of expertise on tap; first among these is group head Simon Kiddle, a biotechnologist and antibodies sage who “quickly understands the nuances of complex portfolios and provides expert strategic advice”. The “very approachable” Simon Kremer is an authority on the pharmaceutical lifecycle, whose scientific prowess is lauded by the universities he works with: “Dr Kremer’s knowledge of science is excellent and he quickly understands the specifics of the proposed inventions”. Fellow life sciences wizards Nick Sutcliffe and Robert Watson together manage a vital patent portfolio for KuDOS Pharmaceuticals, an AstraZeneca company. Sutcliffe has keen insight in the field of antibodies and recombinant proteins, and is “very quick to understand the core of the invention and deploy the best strategy to protect it”; while Oxford-educated Watson balances his penchant for antibody-drug conjugate patents with a thriving designs practice. Also well versed in antibodies are Sean Walton and Christopher Denison. With close to three decades of experience, Walton is a safe pair of hands for EPO oppositions and appeals; while Cambridge-educated Denison has also carved a foothold in the niche area of functional foods. On the engineering side, clients appreciate the solutions that Simon Parry dreams up for all their patent protection problems. “With the inventions that are of most importance to our company, we turn to Simon,” says one. Together with Parry, Stephen Gill leads a team that drafts around 100 patents each year for a global aeronautics company. Another key asset is chemistry doyen Jeremy Webster, who has a high success rate in oppositions and appeals at the EPO and effortlessly coordinates global portfolio management for Japanese multinationals.

Mishcon de Reya LLP

Mishcon de Reya’s crack squad of litigators “offers a dependable and highly professional service”. The ensemble relishes the cut and thrust of high-profile disputes across all sectors and in all forums, including appeal courts and the CJEU; it also has a flair for untangling the IP aspects of complex commercial agreements. Leading the charge is the “calm and objective” David Rose, an “outstanding adviser on all IP questions, whose advice is always goal and customer oriented”. The well-rounded practitioner is as familiar with an SPC as with an SEP, and with technologies as varied as automotive, pharmaceuticals, agrochemicals and telecoms. His brother in arms is Martyn Hann: “Fast-talking, deeply immersed and full of ideas, he perseveres until we reach the best possible outcome in any situation.” With a forte in the life sciences, he lends his acumen to both infringement disputes and licensing matters.

Norton Rose Fulbright LLP

Despite some significant personnel losses on the litigation side, the transactional practice at Norton Rose Fulbright – under the command of Mike Knapper – has kept the firm very much on the map this year. Knapper’s matchless mastery of the fintech space has made the team a market leader in the field, in which he advises a plethora of innovators, including banks and multinationals. He also helps to get licensing agreements inked and patent portfolio sales closed, both on a standalone basis and within the context of mergers and acquisitions. On the contentious front, activity bubbles away thanks to the presence of some up-and-coming litigators who have lately been showcasing their skills in complex SEP-related litigation in the telecoms space.

Osborne Clarke

The patent group at Osborne Clarke juggles high-value litigation with portfolio management for a lengthy roster of household names. The practice kicked up a gear recently with the arrival of Will James, a dynamic litigator who can regularly be tracked down to the High Court, where he has recently been litigating patents for global positioning system and radio-frequency identification technology. “His advice is always pragmatic and commercially relevant, he is very responsive and he strives to provide the best service possible.” Fellow pacesetter Arty Rajendra has been making waves in the Supreme Court in the ubiquitous Unwired Planet v Huawei and in the High Court for mobile phone accessory frontrunner Popsockets. The CVs of both of these leading individuals reflect the firm’s overall technology focus.

Pinsent Masons 

Pinsent Masons adopts a holistic approach to patent protection, providing pragmatic, business-minded advice on some of the country’s most transformative lawsuits and commercial transactions, especially within the telecoms sector. The firm is also extremely active in the life sciences, where it has found its groove representing generics. Clare Tunstall is the lodestar here: a “very talented strategist who knows the ropes inside out”, she is “fantastic – nothing is too much trouble. Clients love her and she gets and retains work as much for this reason as for her substantial litigation skills”. Fighting alongside Tunstall is the redoubtable Charlotte Weekes, who stands out for her “attention to detail and willingness to go the extra mile for clients”. At the heart of the transactional practice is Allistair Booth, who over the course of his career has worked on more than 20 life sciences transactions worth more than $100 million, including collaboration and partnering agreements, asset sales and purchases, and manufacturing and outsourcing arrangements.

Potter Clarkson LLP

Potter Clarkson has many strings to its bow, as evidenced by its inclusion in all three IAM Patent 1000 tables this year. Crucially, however, it conceives of itself as a single team, with patent attorneys regularly pairing up with solicitors to best serve the specific requirements of each brief. This integrated approach goes down a storm with clients: “It is very beneficial, effective and smooth to have the different professionals working together over these different areas.” The prosecution division consists of an all-star line-up of patent attorneys, including Richard Bassett, Stephen McNeeney and Ian Dee, all of whom all have vast experience in oppositions and appeals before the EPO. Dee boasts valuable in-house insight, having started his career in a large multinational chemical corporation; McNeeney is a life sciences strategist with a cosmopolitan perspective; and biochemist Bassett has walked the corridors of the firm since 1986. Working alongside them, computer and software boffin Ray Charig “quickly comes up to speed with complex technologies and is sensitive to business objectives when developing patent strategies”; clients suggest that “his attention to detail has rubbed off on his colleagues”. The prosecution squad is rounded off by Saiful Khan – “a delight to work with because he is very responsive, sharp, warm and honest”; and Charlotte Crowhurst, who has the Midas touch with Asian businesses – she frequently hosts seminars for leading players in China, Korea and Taiwan to provide guidance on protecting inventions in the European market. Recognised for his “extensive technical and commercial expertise”, Peter Finnie is a “leader in the field” who works with a long and growing list of European start-ups, advising them on the development of their IP strategies. Alongside Fiona Stevens, he is a valuable lateral hire for Potter Clarkson – the technically astute practitioners should bring in a slew of new instructions in the months and years to come. Whereas Finnie’s forte is engineering, Stevens is hailed for her pharmaceutical expertise, in particular with regard to SPCs. One client reports: “Fiona is a delightful person to know and has proven very effective in guiding our overall patent strategy. I can unequivocally say that she is the best patent agent I have worked with in over 45 years in the industry.” On the contentious front, Oliver Laing has got it all: “outstanding technical ability under constant time pressures”, a “strategic commercial approach” and the “ability to deal with the anxieties of clients in a professionally empathetic manner”. He also shares a busy transactional practice with colleague Mark Snelgrove, a skilled interpreter of agreements and legislation whose communications are clear and concise.

Powell Gilbert LLP

Clients seeking “excellent strategic advice that is practical and commercially focused, supported by strong legal analysis” should look no further than Powell Gilbert. Home to one of the largest IP litigation teams in the country, it is described as “the go-to firm in the United Kingdom for pharmaceutical and biotech-related matters”, with a “consistently high work product”. The practice is by no means restricted to the life sciences, however, as evidenced by its involvement in Unwired Planet v Huawei, in which partners Simon Ayrton, Zoë Butler and Peter Damerell played vital roles. Ayrton and Butler are an impressive duo: “Professional, organised, calculated, and strategic, they are always mindful of business interests and are exactly what you’d want in outside counsel.” Both share their expertise and help to nurture the litigators of tomorrow by teaching on the reputable Oxford University Diploma in Intellectual Property Law and Practice. Damerell is “a pragmatic and very experienced litigator with an excellent technical understanding and good business acumen, who is successful in balancing attention for detail against keeping the overall goal in mind and staying focused on the key issues of the case”. This combination of technical know-how and legal virtuosity is shared by Ari Laakkonen, who “does an extremely thorough job of preparing a case for trial and knows how best to strategise across jurisdictions”. Both he and Damerell are acclaimed as “among the best IP litigation lawyers not just in England, but anywhere in the world”. Healthcare specialist Timothy Powell is adept at coordinating simultaneous litigations across Europe, North America and beyond; while Penny Gilbert’s molecular biology background proves priceless when advising major movers in the life sciences sector. The “focused and sharp patent strategist and litigator” brings stacks of SPC wisdom to the table. Bethan Hopewell and Tim Whitfield both have “strong scientific understanding and excellent patent skills”; the pair impress with their flawless coordination of multi-jurisdictional suits. Molecular biologist Hopewell also speaks the language of telecoms clients; while Whitfield is a “sharp, clever practitioner” whose practice encompasses pharmaceuticals, medical devices and electronics. Equally versatile is polyglot Alex Wilson, a UPC visionary and European litigator who has served time at leading firms in Paris and Dusseldorf; he is “brimming with tact and good judgement”. Finally, a well-deserved newcomer to the IAM Patent 1000 this year is Siddharth Kusumakar, who recently did battle for Actavis in the Supreme Court and will appear there again in 2020 on behalf of Kymab. His qualifications in immunology come in very handy in complex international life sciences disputes.

Reddie & Grose LLP

“Safe pair of hands” Reddie & Grose is a “highly reliable source of patent prosecution advice”. Its patent attorneys dedicate their time to the hard graft of drafting patents and building expansive patent portfolios from scratch, while also advising on contentious matters such as revocations and oppositions. Working across all sectors, it is particularly prominent in the electronics and software field and is hailed for its client-focused approach. This is embodied by Nick Reeve, a “highly personable, friendly and collaborative” electronics expert who knows his way around the Japanese market and is fluent in Japanese. Engineering and automotive expert Paul Loustalan has a particular niche in underwater vehicles; while Michael Roberts is a life sciences maven who, alongside patent drafting, also advises on due diligence and freedom to operate. New to the IAM Patent 1000 this year are William Ponder – a physicist with patent searching and drafting acumen and abundant experience of oppositions at the EPO; and Neil Thornton. Thornton is reportedly “a delight to work with – commercial in his approach and inventive in suggesting routes to overcome patent application hurdles”.

Reed Smith LLP

Reed Smith is a rare beast, with a potent presence on both coasts of the United States, as well as in all key European jurisdictions. The UK office is another jewel in the crown and its crack IP litigators have been up to their necks in high-stakes cases this year, most of which have a transatlantic or pan-European component. Leading the practice is strategist Jonathan Radcliffe, who is “legally top notch, but also commercially very grounded”. He has deep technical and scientific know-how across a range of technologies and garners glowing reviews from peers: “I have never met a client who wasn’t happy with the quality of his work in almost 30 years.” Colleague Philip Thomas operates at the crossroads of IP and data protection law, and has technical expertise in the maritime and life sciences fields.

Schlich Ltd

Prosecution shop Schlich Ltd covers everything from patent searching to freedom-to-operate advice and analysis, and directs filings in numerous jurisdictions – all from its unique base on the south coast of England. The team is made up of a legion of chemists and biochemists, who file with alacrity not only for pharmaceutical SMEs, but also for innovators in the medical devices, food technology and waste treatment fields. Captaining the ship is the eponymous George Schlich, a scientific all-rounder whose varied expertise encompasses vaccines, stem cell technologies and missile guidance systems, among other things. He also has his finger on the pulse when it comes to CRISPR technologies; clients in this nascent area include Intellia Therapeutics. Like many of his colleagues, he has spent more than his fair share of time at the EPO on oppositions and appeals.

Simmons & Simmons LLP

Simmons & Simmons has the distinction of featuring in all three IAM Patent 1000 tables this year, after it expanded its offering in 2018 with the launch of a pan-European prosecution practice. The architect of this is Kevin Cordina, whose highly commercial approach resonates with big-name electronics and pharmaceutical clients. Technically capable in cellular technologies and medical devices, he has an impressive track record in both managing and defending lucrative patent portfolios. The growing prosecution group dovetails neatly with the firm’s celebrated contentious team, which wins plaudits for its work on high-rolling life sciences suits for the likes of Gilead. Microbiologist Scott Parker was kept busy this year on pan-European SPC litigation for the US biotech giant; he is a “trusted adviser on high-profile complex litigation”. Fellow pharmaceutical expert Kevin Mooney is a “renowned” patent litigator who is currently chairing the committee responsible for drafting the rules and procedure of the UPC. Another thought leader on the litigation squad is Michael Burdon, an “excellent patent litigator” who currently chairs the UK Intellectual Property Lawyers Association He blends keen pharmaceutical know-how with a sophisticated understanding of issues pertaining to FRAND and SEPs. IAM Patent 1000 newcomer Priya Nagpal knows emerging technologies such as AI and blockchain like the back of her hand; her star is on the ascendant thanks to polished performances in contentious scenarios. One client reports: “Priya handled some very tense situations with professionalism and I was impressed by how easily she grasped some of the complex technical issues we had to address.” Also familiar with AI and other bleeding-edge technologies is co-head of the digital health group Michael Gavey, who has facilitated many cross-sector collaborations involving academic institutions, major industry players and governments as part of his transactional practice.

Slingsby Partners LLP

The team at Slingsby Partners lives and breathes original patent drafting, and demonstrates particular strength in electronic engineering and telecoms – areas in which many members have industry experience. Several have also chalked up stints in the mechanical engineering, aerospace and automotive spaces; but whatever the technology, the firm can handle the brief. Its client-centric approach earns it many fans: “Slingsby feels more like an extension of our business, rather than an external supplier, such is its knowledge of our products, processes and people. The team is exceptionally impressive technically and has evident enthusiasm for its work and for the success of our company.” Namesake Philip Slingsby’s 30-year career includes a decade spent in-house at Nokia tackling licensing negotiations for SEPs – experience which informs his practice to this day; his remit also includes drafting software patents and advising on litigation involving US-based patents. Fellow partner David King is likewise skilled at assisting European companies with US litigation and files watertight applications in areas as diverse as electronics, automotive and software. Another software maven is Paul Roberts, who provides incisive guidance on the development of portfolios in the hot area of machine learning.

Stephenson Harwood LLP

Effortlessly traversing the contentious/non-contentious divide, Stephenson Harwood litigates with brio, while also assisting patent holders with licensing, technology transfers and R&D and collaboration agreements. Always on the lookout for effective and innovative solutions, it appraises every mandate with a creative, commercial eye. Thanks to this refreshing approach, it is routinely enlisted by pharmaceutical multinationals for high-stakes, high-value transactional work. This side of the practice was recently boosted by the arrival of Naomi Leach, who has a percipient take on M&A deals and multi-jurisdictional joint venture arrangements. She works her magic alongside Alexandra Pygall, whose “really incisive mind” grants her “invaluable creative insight”. According to one client of five years’ standing, Pygall is “a tremendous professional with strong business acumen, a pragmatic approach and ability to summarise key risks and solutions”. On the contentious front, the big guns include the formidable Rob Jacob, an “absolute star who takes a robust, sensible but knowledgeable approach to adversarial proceedings”. “If you want to be aggressive in a conflict, his style is exceedingly tough, while retaining a sense of reasonableness with the other side.” Newly appointed CEO and fellow litigator Eifion Morris is a “huge client pleaser, with an unparalleled ability to understand commercial requirements and translate them into legal success”.

Taylor Wessing

Despite a number of departures over the last year, Taylor Wessing remains firmly on the radar thanks to its deep bench of litigators, who continue to impress. These include Matthew Royle, who knows everything there is to know about SPCs. His PhD in molecular immunology serves him well when coordinating cross-border pharmaceutical and biotech disputes. Also highly capable in this space is Simon Cohen; he heads both the international patents group and the life sciences group, and provides cogent advice to pharmaceutical companies on preliminary injunctions and issues of patent infringement and validity. Taking charge of the patents group, “highly skilled litigator” Nigel Stoate sticks the landing in engineering, telecommunications, chemical and pharmaceutical disputes, and is no stranger to the High Court and Court of Appeal; likewise accomplished solicitor-advocate James Marshall.

UDL Intellectual Property

The venerable UDL was established 125 years ago and its precision prosecution has become ever sharper over the decades: it recently filed some 453 patent applications during the course of a single year. Six offices across the United Kingdom ensure easy access for companies based all around the country, although the outfit is also a firm favourite of players from Europe and beyond. As a US-qualified patent agent, Andrew Alton proves an invaluable asset on international briefs. The electronics and software sage has boundless insight on patentability, having served as an examiner at the UKIPO. “Andrew’s assessments of communications from the EPO are clear and focused on the essential requirements; while his critiques and comments are succinct and frank. He provides an excellent service, effective communications, diligent attention to detail and honesty.” In the life sciences, the learned Simon Mitchell has niche expertise in human and animal health and food security. An academic for 11 years prior to joining the profession, he has amassed encyclopaedic scientific knowledge, which informs his thoughtful, reliable advice. A recent highlight was work on behalf of Benchmark Holdings PLC, leading appeal proceedings relating to veterinary pharmaceutical dosage regimes.

Venner Shipley LLP

With dual prosecution and litigation capabilities, Venner Shipley meets and exceeds all patent needs of its rapidly growing client base from four offices across the United Kingdom and a fifth in Germany. Thanks to its deep technical acumen, the firm has been pushing the envelope at the EPO of late, developing the law on computer-implemented inventions. The prosecution division attracts effusive testimonials: “Everyone I work with at Venner seems to be creative and digs deeper in their approach to working on each case. When they have that going for them – in addition to timeliness, technical expertise and good judgement – you can see why they’re my favourite European counsel.” Jan Walaski, Paul Derry and Pawel Piotrowicz are the trio of electronics experts at the heart of the team. Walaski balances the roles of head of the electronics and engineering group and managing partner, while also prosecuting patent applications in a wide variety of software fields, including business-related software. He shares this specialism with Piotrowicz, whose Cambridge PhD in semiconductors makes him an essential resource for everyone from multinationals to start-ups and private investors, as well as for the universities and other institutions at which he regularly lectures on intellectual property. Derry, meanwhile, is a telecoms expert who previously worked a patent examiner at the UKIPO and now spends his time drafting meticulous patent specifications and prosecuting patent applications both domestically and before the EPO. On the mechanical engineering side, Alex Brown, whose specialisms include industrial machinery and automotive and aerospace technology, impresses with his commercially-focused advice and drafting and prosecution experience before the UK and European patent offices. Heading up the life sciences and chemical group is Siân Gill; her greatest hits include high-profile cases on blockbuster drugs for respiratory disorders. At the fore on the contentious front is James Tumbridge, who embodies the firm’s one-stop shop status, with an active commercial and alternative dispute resolution practice that complements his IP litigation work. With 35 years at the IP coalface behind him, Paul Harris remains best known for his precedential defence of Black & Decker; like Tumbridge, the versatile practitioner has also cultivated a thriving confidential information practice. Looking to the future, “Venner appears to be highly successful at recruiting strong candidates to form its next generation of attorneys”.

Wiggin LLP 

The patent practice at Wiggin has continued on its steep upwards trajectory this year, thanks to the responsiveness and flexibility of its “top-notch” practitioners, who can swiftly assemble into whatever formation is most appropriate to a given brief. This elasticity makes the team a potent force in technical areas as varied as automotive, horticultural equipment, medical devices and sports goods. The compass of “phenomenal lawyer” Sara Ashby is just as broad; she also shares insight from her illustrious 20-year career as a lecturer on Oxford University’s postgraduate diploma in IP law and practice and as president of the International Association for the Protection of Intellectual Property. She joined Wiggin in 2017, when it merged with specialist IP boutique Redd, together with fellow warrior Michael Browne. A veteran of patent entitlement proceedings in the High Court and patent infringement proceedings in the IPEC, Browne – like Ashby – has been appointed to teach on the Oxford postgraduate course. Transactional aficionado Simon Chalkley dispenses IP licensing advice to innovation-led businesses in fast-moving sectors such as video games and AI. He is “an absolutely solid lawyer, who really is passionate about his work and gives back”; as testament to this, he serves as president of the Licensing Executives Society for Britain and Ireland.

Wilmer Cutler Pickering Hale and Dorr LLP

Global titan WilmerHale has a flag firmly planted on the UK patent litigation landscape; the UK team combines seamlessly with its counterparts in the United States and elsewhere around the globe, giving it enviable geographical scope, which is appreciated by clients. “Very few law firms have the worldly reach that WilmerHale has built,” reports one. “I elected to try them out and am highly pleased I did.” A-list technology and life sciences players have Cambridge-educated Justin Watts on speed dial; his litany of successes in complex multi-jurisdictional disputes includes staunch defence of Johnson & Johnson in an infringement action across a whopping 11 jurisdictions. He also co-led the team that secured one of the highest-ever patent awards, in BMS v Merck, alongside partner Matthew Shade. Equally adept at handling sprawling cross-border suits, Shade mixes his patent activities with a strong antitrust practice. Finally, innovative solutions come naturally to solicitor-advocate Anthony Trenton, who earned acclaim for his role in the landmark Schütz v Werit in the Supreme Court.

Other recommended experts

Commercially focused Ben Appleton of Wilson Gunn spent several years as in-house counsel at a multinational confectionery company, and knows exactly what it takes to delight clients in the food and drink, medical devices and consumer goods sectors. “He has a keen eye for identifying whether an invention is patentable and is skilled in drafting claims to ensure the broadest protection.” Fresh from his 16-year tenure as head of life sciences at Taylor Wessing, Malcolm Bates has given the Goodwin Procter life sciences group a real shot in the arm; he marries molecular biology expertise with broad knowledge of licensing and regulatory matters. Working out of Abel & Imray, patent attorney Paul Brady is the go-to for any SPC questions and also lectures on the subject; he juggles this specialism with precision prosecution and transactional opinion work for companies of all stripes. Tom Carver is a technical all-rounder who is no stranger to cross-border infringement and validity disputes. The former JA Kemp contentious division captain recently joined gunnercooke. Murgitroyd’s Helga Chapman has deep engineering know-how and is applauded by industry heavyweights for her “exceptional and thorough service”. US giant Baker Botts continues to make waves on the UK scene thanks to the efforts of Neil Coulson, whose practice encompasses dispute resolution in areas ranging from oil and gas to pharmaceuticals, and advice on licensing issues and corporate transactions. “He is a great lawyer who always gets positive results.” Life sciences sage Ralph Cox at Clyde & Co is an “incredibly thorough litigator who will drill down into every little detail and leave no stone unturned”. The founder of Innovate Legal, Duncan Curley is a synthetic organ chemistry specialist who advises on claims before the High Court, the Court of Appeal and the Supreme Court; he is also a respected commentator on IP matters. At Haley Guiliano, Peter Hale’s naval engineering background comes in handy when managing large patent portfolios in the fields of communications, control systems, mechanics and thermodynamics. Dentons’ Justin Hill is invariably up to speed on the latest computer technology developments; his remit includes managing international patent portfolios, appearing before the EPO and providing infringement and validity opinions. Operating out of Brown Rudnick, Mark Lubbock provides incisive guidance on IP-rich commercial agreements; Midatech Pharma recently benefited from his wisdom as it negotiated the agreement for its sale to Kanwa Holdings. Alastair McCulloch at Jones Day draws judiciously on the firm’s pan-European resources both when litigating patent litigation and when engaged on closely linked trade secrets and arbitration briefs. The “totally brilliant” Susie Middlemiss is head of intellectual property at Slaughter and May; she has extensive experience litigating in the High Court and advising on all manner of IP transactions in the pharmaceuticals, biotech and healthcare sectors. From her new home at McCarthy Denning, Jennifer Pierce excels at shepherding deals to a successful close: “Her advice is the ideal blend of experience, expertise and practical common sense. She can draw on a remarkable span of experience, in terms of both depth and breadth, enabling her to provide advice even in particularly complex situations.” One satisfied client enthuses: “In my line of business, I interact with many lawyers both in the United Kingdom and overseas. I can honestly say that Jennifer’s advice is among the best I have ever received.” Life sciences, engineering and publishing are all fortes for transactions wizard Chris Shelley; the Penningtons Manches Cooper practitioner has recently been busy acting for Oxford University Press on the IP aspects of its acquisition of educational publisher Nelson Thornes from the Infinitas Group. Baker McKenzie’s UK patent litigation ace is Hiroshi Sheraton, a “strategic thinker, excellent negotiator and strategist” who has been hard at work for L’Oréal recently in ongoing proceedings against RN Ventures. “Hiroshi provides clear advice, taking into account both the intricacies of European law – which he understands in great detail – and the global perspective. More than that, he is highly responsive and his advice is insightful.” Arnold & Porter’s Ewan Townsend has lately been acting for Novartis on the crucial divestment of two of its subsidiaries to Aurobindo Pharma USA Inc. Dispensing perceptive guidance on both IP and regulatory matters, Townsend is “a pleasure to work with” and “excellent in terms of both his technical knowledge and his commercial understanding”. Life sciences doyen Anthony Tridico is managing partner of Finnegan’s London office; his knowledge of legal systems globally is invaluable on multi-jurisdictional patent prosecution briefs. “He is fun, quick and sees legal issues, and can offer creative solutions.” Pharmaceutical multinationals and oil and gas corporations rely on AA Thornton’s Craig Turner to robustly defend patents in the most torrid oral proceedings. Solicitor-advocate David Wilkinson of Ashurst LLP puts in persuasive performances before the English courts and the CJEU, while also teasing out the IP aspects of corporate transactions in fields including consumer goods and telecoms.

Individuals: litigation

  • Dominic Adair - Bristows LLP
  • Stephen Bennett - Hogan Lovells
  • Daniel Brook - Hogan Lovells
  • Neville Cordell - Allen & Overy LLP
  • Brian Cordery - Bristows LLP
  • Nicola Dagg - Kirkland & Ellis LLP 
  • Marc Döring - Allen & Overy LLP
  • Huw Evans - Gowling WLG
  • Mike Gilbert - Marks & Clerk
  • Penny Gilbert - Powell Gilbert LLP
  • Mark Hilton - Bird & Bird LLP
  • Myles Jelf - Bristows LLP
  • Morag Macdonald - Bird & Bird LLP
  • Sebastian Moore - Herbert Smith Freehills LLP
  • Gary Moss - EIP Europe LLP
  • Marjan Noor - Allen & Overy LLP
  • Timothy D Powell - Powell Gilbert LLP
  • Sophie Rich - Herbert Smith Freehills LLP
  • Richard Vary - Bird & Bird LLP
  • Justin Watts - Wilmer Cutler Pickering Hale and Dorr LLP
  • Alex Wilson - Powell Gilbert LLP
  • Sara Ashby - Wiggin LLP 
  • Simon Ayrton - Powell Gilbert LLP
  • Camilla Balleny - Carpmaels & Ransford LLP
  • James Boon - Bristows LLP
  • Paul Brown - Hogan Lovells
  • Zoë Butler - Powell Gilbert LLP
  • Peter Damerell - Powell Gilbert LLP
  • Mark Daniels - Browne Jacobson LLP
  • Gordon Harris - Gowling WLG
  • Mark Heaney - Allen & Overy LLP
  • Bethan Hopewell - Powell Gilbert LLP
  • Paul Inman - Gowling WLG
  • William James - Osborne Clarke
  • Neil J Jenkins - Bird & Bird LLP
  • Ian Karet - Linklaters LLP
  • Ian Kirby - Carpmaels & Ransford LLP
  • Ari Laakkonen - Powell Gilbert LLP
  • Daniel Lim - Kirkland & Ellis LLP 
  • Eifion Morris - Stephenson Harwood LLP
  • Jane M Mutimear - Bird & Bird LLP
  • Scott Parker - Simmons & Simmons LLP
  • Mark Ridgway - Allen & Overy LLP
  • David Rose - Mishcon de Reya LLP
  • Hiroshi J Sheraton - Baker McKenzie
  • Katharine Stephens - Bird & Bird LLP
  • Nigel Stoate - Taylor Wessing
  • Christopher Stothers - Freshfields Bruckhaus Deringer LLP
  • James R Tumbridge - Venner Shipley LLP
  • Clare Tunstall - Pinsent Masons 
  • Tim Whitfield - Powell Gilbert LLP
  • David Wilson - Carpmaels & Ransford LLP
  • Steven Baldwin - Kirkland & Ellis LLP 
  • Jonathan Ball - Gowling WLG
  • Dafydd Bevan - Marks & Clerk
  • Deborah Bould - DLA Piper UK LLP
  • Andrew Bowler - Bristows LLP
  • Alexandra Brodie - Gowling WLG
  • Michael Browne - Wiggin LLP 
  • Michael Burdon - Simmons & Simmons LLP
  • Graham Burnett-Hall - Marks & Clerk
  • Robert Burrows - Bristows LLP
  • Tom Carver - gunnercooke LLP
  • Liz Cohen - Bristows LLP
  • Simon Cohen - Taylor Wessing
  • Neil Coulson - Baker Botts LLP
  • Ralph Cox - Clyde & Co LLP
  • Antony Craggs - D Young & Co LLP
  • Duncan Curley - Innovate Legal
  • Kathleen Fox Murphy - EIP Europe LLP
  • David Fyfield - Charles Russell Speechlys
  • Martyn Hann - Mishcon de Reya LLP
  • Paul A Harris - Venner Shipley LLP
  • Rob Jacob - Stephenson Harwood LLP
  • Jennifer Jones - Bird & Bird LLP
  • Matthew Jones - EIP Europe LLP
  • Patrick Kelleher - Bird & Bird LLP
  • Richard Kempner - Haseltine Lake Kempner LLP 
  • Siddharth Kusumakar - Powell Gilbert LLP
  • Oliver Laing - Potter Clarkson LLP
  • Yohan Liyanage - Linklaters LLP
  • Robert Lundie Smith - EIP Europe LLP
  • James Marshall - Taylor Wessing
  • Katie McConnell - Hogan Lovells
  • Alastair McCulloch - Jones Day
  • Susie Middlemiss - Slaughter and May
  • Andrew Moir - Herbert Smith Freehills LLP
  • Michael Moore - Marks & Clerk
  • Gareth E Morgan - CMS Cameron McKenna Nabarro Olswang LLP
  • Priya Nagpal - Simmons & Simmons LLP
  • Giles Parsons - Browne Jacobson LLP
  • Jonathan Radcliffe - Reed Smith LLP
  • Arty Rajendra - Osborne Clarke
  • Jamie Rowlands - Gowling WLG
  • Matthew Royle - Taylor Wessing
  • Matthew Shade - Wilmer Cutler Pickering Hale and Dorr LLP
  • Mark Shillito - Herbert Smith Freehills LLP
  • Joel Smith - Herbert Smith Freehills LLP
  • Richard Taylor - DLA Piper UK LLP
  • Anthony Trenton - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jonathan Turnbull - Herbert Smith Freehills LLP
  • Charlotte Weekes - Pinsent Masons 
  • Laura Whiting - Freshfields Bruckhaus Deringer LLP
  • David Wilkinson - Ashurst LLP
  • Robert Williams - Bird & Bird LLP
  • Richard Willoughby - D Young & Co LLP

Individuals: prosecution

  • Harvey Adams - Carpmaels & Ransford LLP
  • Richard Bassett - Potter Clarkson LLP
  • Kristina Cornish - Kilburn & Strode LLP
  • Devanand Crease - Keltie LLP
  • Peter Finnie - Potter Clarkson LLP
  • Hugh Goodfellow - Carpmaels & Ransford LLP
  • Richard Howson - Kilburn & Strode LLP
  • Ilya Kazi - Mathys & Squire LLP 
  • Alexander Korenberg - Kilburn & Strode LLP
  • Cameron Marshall - Carpmaels & Ransford LLP
  • Nick McLeish - Boult Wade Tennant LLP
  • Jim Miller - Kilburn & Strode LLP
  • Gwilym Roberts - Kilburn & Strode LLP
  • Rohan P Setna - Boult Wade Tennant LLP
  • Jerome Spaargaren - EIP Europe LLP
  • Shakeel Ahmad - Keltie LLP
  • Anthony Albutt - D Young & Co LLP
  • Andrew Alton - UDL Intellectual Property
  • Ben Appleton - Wilson Gunn
  • Peter Arrowsmith - Gill Jennings & Every LLP
  • Nick Bassil - Kilburn & Strode LLP
  • Simon Bradbury - Appleyard Lees 
  • Adrian Bradley - Cleveland Scott York
  • Paul Brady - Abel & Imray
  • Alex Brown - Venner Shipley LLP
  • Fraser Brown - Cleveland Scott York
  • Laurence Brown - EIP Europe LLP
  • John Brunner - Carpmaels & Ransford LLP
  • Judith Caldwell - Keltie LLP
  • Patrick Campbell - J A Kemp
  • Matthew Cassie - HGF Ltd
  • Helga C Chapman - Chapman IP Ltd
  • Ray Charig - Potter Clarkson LLP
  • Hsu Min Chung - HGF Ltd
  • Jane Clark - Mathys & Squire LLP 
  • Arnie Clarke - Gill Jennings & Every LLP
  • Kevin Cordina - Simmons & Simmons LLP
  • Charlotte Crowhurst - Potter Clarkson LLP
  • Philip Cupitt - Marks & Clerk
  • Christopher Davies - Dehns
  • Ian Dee - Potter Clarkson LLP
  • Christopher Denison - Mewburn Ellis LLP
  • Paul Derry - Venner Shipley LLP
  • Garreth Duncan - D Young & Co LLP
  • Tom Faulkner - Cleveland Scott York
  • Kirk Gallagher - D Young & Co LLP
  • Tom Gaunt - Lewis Silkin
  • Siân Gill - Venner Shipley LLP
  • Stephen Gill - Mewburn Ellis LLP
  • Jonathan Goodacre - Keltie LLP
  • Jonathan Gowshall - Forresters
  • Peter Hale - Haley Guiliano LLP
  • Chris K Hamer - Mathys & Squire LLP 
  • David Hammond - Haseltine Lake Kempner LLP
  • Charles T Harding - D Young & Co LLP
  • Adrian Hayes - Boult Wade Tennant LLP
  • Justin Hill - Dentons 
  • Jane Hollywood - CMS Cameron McKenna Nabarro Olswang LLP
  • Joanne Hopley - Keltie LLP
  • Harry Hutchinson - HGF Ltd
  • Jonathan Jackson - D Young & Co LLP
  • Richard E Jackson - Carpmaels & Ransford LLP
  • Lucy Johnson - HGF Ltd
  • Nonny Jones - Alembia Intellectual Property Ltd
  • Saiful Khan - Potter Clarkson LLP
  • Simon Kiddle - Mewburn Ellis LLP
  • David King - Slingsby Partners LLP
  • Susan E Kirsch - Carpmaels & Ransford LLP
  • Simon Kremer - Mewburn Ellis LLP
  • Matt Lawman - EIP Europe LLP
  • David Leckey - Dehns
  • Nick Lee - Kilburn & Strode LLP
  • Tom Leonard - Kilburn & Strode LLP
  • Paul Loustalan - Reddie & Grose LLP
  • Andrew Mackenzie - Cleveland Scott York
  • Martin MacLean - Mathys & Squire LLP 
  • Philip Martin - Marks & Clerk
  • Heather McCann - EIP Europe LLP
  • Stephen McNeeney - Potter Clarkson LLP
  • Simon Mitchell - UDL Intellectual Property
  • Chris Moore - HGF Ltd
  • Michael Moore - Keltie LLP
  • Colm Murphy - Cooley LLP
  • Neil Nachshen - D Young & Co LLP
  • Will Nieuwenhuys - Marks & Clerk
  • Simon O'Brien - D Young & Co LLP
  • Edward Oates - Carpmaels & Ransford LLP
  • Lucy Padget - Alembia Intellectual Property Ltd
  • Jonathan Palmer - Boult Wade Tennant LLP
  • Simon Parry - Mewburn Ellis LLP
  • Pawel Piotrowicz - Venner Shipley LLP
  • Tony Pluckrose - Boult Wade Tennant LLP
  • William Ponder - Reddie & Grose LLP
  • Simon Rees - Haseltine Lake Kempner LLP
  • Nick Reeve - Reddie & Grose LLP
  • Mark Roberts - J A Kemp
  • Michael Roberts - Reddie & Grose LLP
  • Paul Roberts - Slingsby Partners LLP
  • Alex Rogers - Haseltine Lake Kempner LLP
  • Sarah Roques - J A Kemp
  • Lucy Samuels - Gill Jennings & Every LLP
  • George Schlich - Schlich Ltd 
  • Heather Scott - Gill Jennings & Every LLP
  • Robert Skone James - Gill Jennings & Every LLP
  • Philip Slingsby - Slingsby Partners LLP
  • Bobby Smithson - Appleyard Lees 
  • Darren Smyth - EIP Europe LLP
  • Matthew Spencer - Boult Wade Tennant LLP
  • Ravi Srinivasan - J A Kemp
  • Robert Stephen - CMS Cameron McKenna Nabarro Olswang LLP
  • Fiona Stevens - Potter Clarkson LLP
  • Nick Sutcliffe - Mewburn Ellis LLP
  • Neil Thornton - Reddie & Grose LLP
  • Craig Titmus - Mathys & Squire LLP 
  • Anthony C Tridico - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Christopher S Tunstall - Carpmaels & Ransford LLP
  • Craig Turner - AA Thornton
  • Jennifer Uno - HGF Ltd
  • Jan Walaski - Venner Shipley LLP
  • Sheila Wallace - Marks & Clerk
  • Helen Wallis - CMS Cameron McKenna Nabarro Olswang LLP
  • Seán Walton - Mewburn Ellis LLP
  • James Warner - Carpmaels & Ransford LLP
  • Robert Watson - Mewburn Ellis LLP
  • Philip Webber - Dehns
  • Jeremy Webster - Mewburn Ellis LLP
  • Andrew Wells - HGF Ltd
  • Nina White - Boult Wade Tennant LLP
  • Daniel Wise - Carpmaels & Ransford LLP
  • Simon Wright - J A Kemp

Individuals: transactions

  • Mark Anderson - Anderson Law LLP
  • Malcolm Bates - Goodwin Procter LLP
  • Richard Dickinson - Bristows LLP
  • Patrick Duxbury - Gowling WLG
  • Jim Ford - Allen & Overy LLP
  • Michael Gavey - Simmons & Simmons LLP
  • Susie Middlemiss - Slaughter and May
  • Daniel Pavin - Covington & Burling LLP
  • Jennifer Pierce - McCarthy Denning Ltd
  • Alexandra Pygall - Stephenson Harwood LLP
  • Chris Shelley - Penningtons Manches Cooper LLP
  • Sally Shorthose - Bird & Bird LLP
  • Joel Smith - Herbert Smith Freehills LLP
  • Matthew Warren - Bristows LLP
  • John Wilkinson - Cooley LLP
  • Lisa Allebone - Anderson Law LLP
  • Allistair Booth - Pinsent Masons 
  • David Brooks - Freshfields Bruckhaus Deringer LLP
  • Simon Chalkley - Wiggin LLP 
  • Nemone Franks - Linklaters LLP
  • Selina Hinchliffe - Browne Jacobson LLP
  • Ian Karet - Linklaters LLP
  • Mike Knapper - Norton Rose Fulbright LLP
  • Janet Knowles - HGF Ltd
  • Oliver Laing - Potter Clarkson LLP
  • Naomi Leach - Stephenson Harwood LLP
  • Yohan Liyanage - Linklaters LLP
  • Mark A Lubbock - Brown Rudnick LLP
  • Nicola Maguire - Cooley LLP
  • Jake Marshall - Carpmaels & Ransford LLP
  • Katie McConnell - Hogan Lovells
  • Michael Moore - Marks & Clerk
  • Eifion Morris - Stephenson Harwood LLP
  • Fiona Nicolson - Bristows LLP
  • Lucinda Osborne - Covington & Burling LLP
  • Nigel Parker - Allen & Overy LLP
  • Morag Peberdy - Covington & Burling LLP
  • Simon Portman - Marks & Clerk
  • Giles Pratt - Freshfields Bruckhaus Deringer LLP
  • Jonathan Radcliffe - Reed Smith LLP
  • Tom Snaith - Bird & Bird LLP
  • Mark Snelgrove - Potter Clarkson LLP
  • Richard Taylor - DLA Piper UK LLP
  • Philip Thomas - Reed Smith LLP
  • Ewan Townsend - Arnold & Porter Kaye Scholer LLP
  • David Wilkinson - Ashurst LLP

Luminaries

  • Gregor Grant - Marks & Clerk
  • Kevin Mooney - Simmons & Simmons LLP
  • Edward J Nodder - Bristows LLP